Dry Eye Syndrome Therapeutics Pipeline Products Under Drug Profile Includes Product Description & Developmental Activiti
The study analyzed that the dry eye syndrome therapeutics pipeline comprises approximately 50 drug candidates in different stages of development. According to the research findings, most of the drug candidates of dry eye syndrome pipeline are being developed to be administered by topical route. InSite Vision (A Sun Pharmaceutical Industries Ltd. company) is using DuraSite technology platform for the development of their drug candidates for the treatment of dry eye syndrome. DuraSite is a drug delivery vehicle that stabilizes small molecules in a polymeric mucoadhesive matrix.
★
★
★
★
★
92 views • 6 slides
